Pancreatic Cancer Research

ResearcherDuke UniversityNo recent work listed

Julie Ann Sosa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3356-7316; OpenAlex author ID A5039439529. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers

Papers 3

  1. Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18 243 patients. Last author DOI 10.1002/jso.24630↗
  2. Impact of minimally invasive vs. open distal pancreatectomy on use of adjuvant chemoradiation for pancreatic adenocarcinoma. Last author DOI 10.1016/j.amjsurg.2017.01.005↗
  3. Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-015-4937-x↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mohamed A. Adam · 3 shared papers, 2016–2017 · strength 0.23
  2. Linda M. Youngwirth · 2 shared papers, 2016–2017 · strength 0.14
  3. Dan German Blazer · 2 shared papers, 2016–2017 · strength 0.14
  4. Daniel P. Nussbaum · 2 shared papers, 2016–2017 · strength 0.14
  5. Kevin L. Anderson · 1 shared paper, 2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.